US equities |
NVDA $239.61 ▲+2.42% SPCX $169.70 ▲+6.76% MU $1,061.67 ▼-1.23% TSLA $380.12 ▲+2.57% SNDK $1,697.17 ▼-1.33% MSFT $528.42 ▲+2.11% INTC $116.28 ▼-2.56% META $744.01 ▲+2.19%
FinancialContent

Zomedica Corp. Common Shares (NY:ZOM)

0.0973 UNCHANGED
Last Price Updated: 8:00 PM EST, Mar 4, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Zomedica Corp. Common Shares

< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
News headline image
Zomedica Launches Two New Quantitative Assays on the TRUFORMA(R) Platform: Canine NT-proBNP and Progesterone
Via ACCESSWIRE
News headline image
Zomedica Appoints Scott A. Jordan Executive Vice President, Finance & Chief Financial Officer
Via ACCESSWIRE
Zomedica Corp (NYSE: ZOM) Featured in Coverage of NobleCon20
Via Investor Brand Network
News headline image
Zomedica to Present at the NobleCon20 Twentieth Annual Emerging Growth Equity Conference December 4, 2024
Via ACCESSWIRE
Larry Heaton, CEO of Zomedica Corp. (NYSE: ZOM), to Present at NobleCon20
Via Investor Brand Network
News headline image
Zomedica Launches Quantitative Insulin Assay for Equine Plasma on the TRUFORMA(R) Platform
Via ACCESSWIRE
News headline image
Zomedica Launches Ear Cytology Quick Scan Protocol for TRUVIEW(TM) Digital Microscope & Telepathology Platform
Via ACCESSWIRE
News headline image
Zomedica Announces Sponsorship of Educational Presentations at the Fetch Coastal Conference
Via ACCESSWIRE
News headline image
Noble Capital Markets Initiates Equity Research Coverage on Zomedica
Via ACCESSWIRE
News headline image
Zomedica to Present at the Sidoti Micro Cap Conference November 14, 2024
Via ACCESSWIRE
News headline image
Zomedica Announces Third Quarter 2024 Financial Results: Revenue Up 10% to $7 Million; 72% Gross Margin, and $78 Million in Liquidity to Support Growth
Via ACCESSWIRE
News headline image
Zomedica to Report Third Quarter 2024 Financial Results and Provide Business Update on November 7th at 4:30 p.m. ET
Via ACCESSWIRE
News headline image
Zomedica Strengthens European Foothold With Grovet Partnership, Expanding PulseVet And TRUFORMA Reach ↗
Zomedica expands partnership with Grovet to distribute equine products in 27 European countries, including Germany, France, and Spain. 
Via Benzinga
News headline image
Zomedica Announces Expansion of Exclusive Equine Distribution Agreement with Grovet in Europe
Via ACCESSWIRE
News headline image
Zomedica Completes Renovation & Upgrade of Manufacturing, Distribution, and R&D Center in Plymouth, Minnesota
Via ACCESSWIRE
News headline image
Zomedica Secures CE Mark for TRUVIEWTM Digital Microscope & Telepathology System, Expanding Global Market Opportunities
Via ACCESSWIRE
News headline image
Zomedica's Assisi Loop(R) Product Line Designated as Fear Free(TM) Preferred Product
Via ACCESSWIRE
News headline image
Zomedica Introduces Enhanced Audio Features for the VETGuardian(R) Zero-touch Vital Signs Remote Monitoring System
Via ACCESSWIRE
News headline image
More Than $9M Bet On Nerdy? Check Out These 3 Penny Stocks Executives Are Aggressively Buying ↗
 
Via Benzinga
News headline image
Zomedica Announces Key Educational Presentations at Fetch dvm360 Veterinary Conference
Via ACCESSWIRE
News headline image
ZOM Stock Earnings: Zomedica Misses Revenue for Q2 2024 ↗
ZOM stock results show that Zomedica missed on revenue for the second quarter of 2024. 
Via InvestorPlace
News headline image
Zomedica Announces Second Quarter 2024 Financial Results: Revenue of $6.1 Million; 71% Gross Margin, and $83.0 Million in Liquidity to Support Growth
Via ACCESSWIRE
News headline image
Zomedica Taps Into Costa Rica With Strategic Partnership With SIRE Veterinario ↗
Zomedica Corp. expands into Costa Rica with SIRE Veterinario as exclusive distributor. Strategic partnership aims to bring advanced veterinary solutions to local veterinarians. 
Via Benzinga
News headline image
Zomedica Continues Global Expansion Through Strategic Partnership with SIRE Veterinario, S.A for Sales Expansion in Central America
Via ACCESSWIRE
News headline image
The United States Eventing Association Names Zomedica’s PulseVet(R) as the Official Shock Wave of the USEA
Via ACCESSWIRE
News headline image
US Equestrian Names Zomedica’s PulseVet System as the Official Shock Wave Therapy of US Equestrian Team Veterinarians
Via ACCESSWIRE
News headline image
Zomedica to Report Second Quarter 2024 Financial Results and Provide Business Update on August 14 at 4:30 p.m. ET
Via ACCESSWIRE
News headline image
Zomedica Expands Global Reach Through Strategic Alliance with Leader Healthcare Group for Sales Expansion in Key International Markets
Via ACCESSWIRE
News headline image
7 ‘Lottery Ticket Stocks’ That Could Turn $1K into $10K ↗
Aggressive investors take note: these seven high-risk. high-reward stocks have the potential to rise in value by as much as 1,000%. 
Via InvestorPlace
News headline image
Zomedica Expands TRUFORMA Addressable Market with Launch of Equine Cortisol Assay for the Platform
Via ACCESSWIRE
< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >